The life sciences’ relationship with technology has come a long way since Deloitte’s 2015 global life sciences outlook describing it as ‘operating in an era of significant transformation.’ Since the report was published, most in the industry have re-evaluated traditional methods of operations, put to bed (or at least put a plan in place to deal with) ineffective, costly, and disjointed systems
and practices, and are embracing the positive change innovative technology can bring. This article by Mark Stevens of Formpipe Life Science suggests embracing this technological revolution to get the most out of the pharmaceutical manufacturing process.